| EPE399 | Factors associated with HIV testing among people who inject drugs: findings from a multistate study in the United States at the start of the COVID-19 pandemic | E-poster | Impact of COVID-19 on HIV testing services |
| EPE401 | Service uptake, client profile, and acceptability of a self-directed HIV and STI screening clinic in Quebec during the COVID-19 pandemic | E-poster | Impact of COVID-19 on HIV testing services |
| EPE402 | MSM / TG communities impacted by covid 19 lockdown resulting in increased hiv prevalence and low testing- anexploratory study from india | E-poster | Impact of COVID-19 on HIV testing services |
| PEMOE38 | Impact of COVID-19 on HIV testing volume and positivity in 16 countries | Poster exhibition | Impact of COVID-19 on HIV testing services |
| PEMOE39 | Measuring the impact of the COVID-19 lockdown on testing services in specialized HIV facilities in Mexico | Poster exhibition | Impact of COVID-19 on HIV testing services |
| EPE403 | Assessing COVID-related concerns and their impact on antenatal and delivery care among pregnant women living with HIV in Kenya | E-poster | Impact of COVID-19 on HIV treatment services |
| EPE404 | COVID-19 affects Ryan White facility utilization in South United States: a place visitation analysis | E-poster | Impact of COVID-19 on HIV treatment services |
| EPE405 | Assessing loss to follow-up in HIV treatment in Tien Giang province during the COVID-19 pandemic | E-poster | Impact of COVID-19 on HIV treatment services |
| EPE406 | Decentralized drug distribution during the COVID-19 surge in Ho Chi Minh City: lessons learned from antiretroviral drug home delivery via postal services | E-poster | Impact of COVID-19 on HIV treatment services |
| EPE407 | Home delivery of antiretroviral drugs in Indonesia, Laos, Nepal and Nigeria: implications of COVID-19 experiences for post-pandemic decentralized ARV delivery | E-poster | Impact of COVID-19 on HIV treatment services |